These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Psychedelic drugs-a new era in psychiatry? . Nutt D Dialogues Clin Neurosci; 2019; 21(2):139-147. PubMed ID: 31636488 [TBL] [Abstract][Full Text] [Related]
3. The emerging role of psilocybin and MDMA in the treatment of mental illness. Gill H; Gill B; Chen-Li D; El-Halabi S; Rodrigues NB; Cha DS; Lipsitz O; Lee Y; Rosenblat JD; Majeed A; Mansur RB; Nasri F; Ho R; McIntyre RS Expert Rev Neurother; 2020 Dec; 20(12):1263-1273. PubMed ID: 32954860 [TBL] [Abstract][Full Text] [Related]
5. [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges]. Majić T; Jungaberle H; Schmidt TT; Zeuch A; Hermle L; Gallinat J Fortschr Neurol Psychiatr; 2017 Jul; 85(7):383-392. PubMed ID: 28768346 [No Abstract] [Full Text] [Related]
6. Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin. Varker T; Watson L; Gibson K; Forbes D; O'Donnell ML J Psychoactive Drugs; 2021; 53(1):85-95. PubMed ID: 32931403 [TBL] [Abstract][Full Text] [Related]
7. Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview. Tabaac BJ; Shinozuka K; Arenas A; Beutler BD; Cherian K; Evans VD; Fasano C; Muir OS Am J Ther; 2024 Mar-Apr 01; 31(2):e97-e103. PubMed ID: 38518266 [TBL] [Abstract][Full Text] [Related]
8. Psilocybin and MDMA for the treatment of trauma-related psychopathology. Bird CIV; Modlin NL; Rucker JJH Int Rev Psychiatry; 2021 May; 33(3):229-249. PubMed ID: 34121583 [TBL] [Abstract][Full Text] [Related]
9. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders. Lowe H; Toyang N; Steele B; Grant J; Ali A; Gordon L; Ngwa W Molecules; 2022 Apr; 27(8):. PubMed ID: 35458717 [TBL] [Abstract][Full Text] [Related]
10. Compassionate use of psychedelics. Greif A; Šurkala M Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195 [TBL] [Abstract][Full Text] [Related]
11. Psychedelic drugs for psychiatric disorders. da Costa SC; Oesterle T; Rummans TA; Richelson E; Gold M J Neurol Sci; 2022 Sep; 440():120332. PubMed ID: 35841696 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic Potential of Psychedelics in the Treatment of Psychiatric Disorders, Part 1: Psychopharmacology and Neurobiological Effects. Hosanagar A; Cusimano J; Radhakrishnan R J Clin Psychiatry; 2021 Feb; 82(2):. PubMed ID: 33988926 [No Abstract] [Full Text] [Related]
16. What is needed for the roll-out of psychedelic treatments? Xenakis SN; Shannon SM Curr Opin Psychiatry; 2024 Jul; 37(4):277-281. PubMed ID: 38726805 [TBL] [Abstract][Full Text] [Related]
17. How ecstasy and psilocybin are shaking up psychiatry. Tullis P Nature; 2021 Jan; 589(7843):506-509. PubMed ID: 33505033 [No Abstract] [Full Text] [Related]
18. Psychedelic drugs: the ups and downs of ecstasy. Check E Nature; 2004 May; 429(6988):126-8. PubMed ID: 15141183 [No Abstract] [Full Text] [Related]
19. Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Sarparast A; Thomas K; Malcolm B; Stauffer CS Psychopharmacology (Berl); 2022 Jun; 239(6):1945-1976. PubMed ID: 35253070 [TBL] [Abstract][Full Text] [Related]
20. Ethical considerations for psychedelic-assisted therapy in military clinical settings. Hoener S; Wolfgang A; Nissan D; Howe E J Med Ethics; 2024 Mar; 50(4):258-262. PubMed ID: 37253556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]